Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Understanding which risk dominates can guide your allocation decisions. This comparison highlights when inflation worry or market dips matter more.
28,524 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
XRP appears to be forming a bottom as it tests a key floor near $1.20 and eyes a breakout above $1.80, with traders w...
Metropolis has surged to a $5 billion valuation after a 2025 funding round, transforming parking networks into a broa...
Someone may call you with a life-changing lottery claim, but the first demand is almost always a fee. This guide brea...
A federal court in New York dismissed a four-year class-action accusing Uniswap Labs of enabling scam tokens on its D...
A new Milken-Harris poll shows 80% of Americans want government-backed AI workforce programs now, with 68% feeling th...
As policy moves shift, top high yield savings accounts are offering higher APYs. This explainer shows how these rates...
A Mexican anti-money laundering move froze a bank account tied to a Miss Universe co-owner as authorities pursue a wi...
Alphabet faces questions about its AI leadership as rivals push flashy advances. Yet Gemini adoption and AI-native in...
A weekend heat wave has buckled the Autobahn near Berlin and halted long-distance trains, upending travel plans and r...
Meta ends end-to-end encryption on Instagram direct messages, signaling a shift in privacy promises. TikTok counters ...
The House rejected a bill to fund the Smithsonian American Women’s History Museum, triggering a partisan clash that l...